Literature DB >> 743711

Repeated phlebographic examination during and after fibrinolytic therapy with streptokinase and urokinase.

E Gmelin, W Theiss.   

Abstract

Forty-three patients with deep vein thrombosis were given fibrinolytic therapy with streptokinase and/or urokinase. In all patients the diagnosis was made phlebographically, and repeat phlebography was performed after termination of therapy. Sixty-four of 104 vein segments initially occluded (62%) were partially or completely recanalized. No vein segments particularly suitable for fibrinolytic therapy could be defined. The therapy was as successful in cases in which the thrombosis extended over several segments as in those in which the occlusions involved only one or two segments. Similarly, there was no difference in the success rate for thrombi that were still freely floating and for thrombi that occluded the veins completely. It is recommended that fibrinolytic therapy be given in suitable cases in which clinical symptoms have persisted up to two weeks; in some cases this limit may even be extended up to one month.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 743711     DOI: 10.1007/bf02552027

Source DB:  PubMed          Journal:  Cardiovasc Radiol        ISSN: 0342-7196


  12 in total

1.  The histological localisation of fibrinolysin activator.

Authors:  A S TODD
Journal:  J Pathol Bacteriol       Date:  1959-07

Review 2.  [Heparin or thrombolysis in the treatment of deep venous thrombosis of the leg].

Authors:  L K Widmer; G Madar; H E Schmitt; F Duckert; M A da Silva; G Müller
Journal:  Vasa       Date:  1974       Impact factor: 1.961

3.  [Late lysis of venous thromboses].

Authors:  V Tilsner
Journal:  Vasa       Date:  1974       Impact factor: 1.961

4.  Thrombolytic effect of streptokinase as evaluated by phlebography of deep venous thrombi of the leg.

Authors:  B R Robertson; I M Nilsson; G Nylander
Journal:  Acta Chir Scand       Date:  1970

5.  [Influence of the 4 thrombus stages on fibrinolysis using streptokinase].

Authors:  R Gottlob; G Blümel
Journal:  Med Welt       Date:  1968-11-30

6.  [Dosage of long-term streptokinase fibrinolytic administration (author's transl)].

Authors:  W Theiss; A Kriessmann; A Wirtzfeld
Journal:  Dtsch Med Wochenschr       Date:  1975-09-19       Impact factor: 0.628

7.  Healing of deep venous thrombosis: venographic findings in a randomized study comparing streptokinase and heparin.

Authors:  J Rösch; C T Dotter; A J Seaman; J M Porter; H H Common
Journal:  AJR Am J Roentgenol       Date:  1976-10       Impact factor: 3.959

8.  Treatment of deep vein thrombosis. A trial of heparin, streptokinase, and arvin.

Authors:  V V Kakkar; C Flanc; C T Howe; M O'Shea; P T Flute
Journal:  Br Med J       Date:  1969-03-29

9.  Late results of treatment of deep vein thrombosis.

Authors:  V V Kakkar; C T Howe; J W Laws; C Flanc
Journal:  Br Med J       Date:  1969-03-29

10.  Streptokinase and deep vein thrombosis.

Authors:  N L Browse; M L Thomas; H P Pim
Journal:  Br Med J       Date:  1968-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.